Dr. Barry Dworkin

Oral version of injectable cholesterol-lowering medication completes phase 3 trial with noted reductions in LDL-cholesterol as well as lipoproteins.

Medical Mythbusting Commentary for February 9, 2026

Source:
Experimental cholesterol-lowering pill may offer new option for millions

Reference:
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

Related posts:

  1. Medications seem to work as well as stents for people with stable heart disease
  2. Are US statin guidelines being too inclusive and leading to overtreatment?
  3. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment
  4. New U.S guidelines for statin use for everyone over 40 needs careful consideration of risks vs benefits and is certainly not for everyone